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1  | INTRODUC TION
The number of deaths due to cancer accounts for about 12% 
of the total deaths each year worldwide, and there are over 
1 000 000 new cases of cancer per year.1 Lung cancer has 
become the leading cause of cancer deaths in humans. Xuanwei 
area in Yunnan province, including Xuanwei, Fuyuan, Qilin and 
Zhanyi Counties (E 103°35′30″ to 104°40′50″, N 25°53′50″ to 
26°44′50″), located in south- western China, has a population 
of about 1.4 million, and its incidence of lung cancer is among 
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Abstract
The Xuanwei area of Yunnan Province, China, is one of the regions suffering from the 
highest occurrence and mortality rate of lung cancer in the world. Local residents 
tend to use bituminous coal as domestic fuel, which causes serious indoor air pollu-
tion and is established as the main carcinogen. After the local government carried out 
furnace and stove reform work, lung cancer rate including incidence and mortality 
among residents remains high. We herein wonder if there are specific mechanisms 
at protein level for the development of non- small- cell lung cancer (NSCLC) in this 
area. We investigated the changes of protein profiling in tumour of the patients from 
Xuanwei area. Tandem mass tag (TMT) was employed to screen the differential pro-
teins between carcinoma and para- carcinoma tissues. We identified a total of 422 
differentially expressed proteins, among which 162 proteins were significantly up- 
regulated and 260 were downregulated compared to para- carcinoma tissues. Many 
of the differentially expressed proteins were related to extracellular matrix (ECM)- 
receptor interaction, focal adhesion, PI3K/AKT pathway and ferroptosis. Further 
experiments on the two differential proteins, thioredoxin 2 (TXN2) and haptoglobin 
(HP), showed that the change of their expressions could make the lung cancer cell 
lines more resistant to erastin or RSL- induced ferroptosis in vitro, and promote the 
growth of tumour in nude mice. In conclusion, this study revealed that aberrant regu-
lation of ferroptosis may involve in the development of lung cancer in Xuanwei area.
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the highest in the world. Especially, the incidence of lung can-
cer among non- smokers is 400/100 000, which is 20 times higher 
than the national average.2,3 Previous studies have associated this 
excessive incidence of lung cancer with the domestic combustion 
of ‘smoky coal’, especially burning the coals in unvented house-
holds.4,5 The smoky coal typically means the locally obtainable 
Late Permian bituminous coal,6 which releases high level of vis-
ible smoke upon combustion. This kind of coal is available from 
many local coal mines within Xuanwei region and constitutes the 
primary fuel source for native residents. Several researches have 
proposed that the smoky coal combustion products like polycy-
clic aromatic hydrocarbons (PAHs) and air pollution fine- grained 
matter such as crystalline quartz particulate are classified as mu-
tagens to human cancer.7,8 The Yunnan Provincial Government 
has carried out furnace and stove reform work in Xuanwei area, 
hoping to reduce the incidence of lung cancer by reducing in-
door coal- burning air pollution. However, the results of the Third 
National Sampling Survey of Cause of Death showed that the lung 
cancer mortality rate in the whole Xuanwei area increased most 
significantly nationwide.9 Therefore, there could be other more 
important carcinogens.
Research to date on alternative potential driver risks for prev-
alent lung cancer in Xuanwei has been revealed. The primary risk 
arises from environmental pollution. The roles of some metal el-
ements, especially heavy metal elements, are partially known in 
carcinogenesis in the context of lung cancer. As studies of Yunnan 
soil are observed, heavy metal pollution with metals of V, Cd, Cr, 
Cu, Mn, Co, Ni, Pb, As and Zn exceeds the vicinities concentrations, 
which denotes these metals have heavily polluted the street dusts 
of Xuanwei. Among which, Cd, Cr, Ni, Cr and As, are considered 
to be carcinogenic for human with long- term dusts exposure, and 
Cr is especially relevant for local children's risk.10 The toxicity of 
Pb on lungs has been found to related to the increases in Nuclear 
factor kappa B (NF- κB) and aryl hydrocarbon receptor (AHR) lev-
els, which further lead to the increases of nitric oxide synthase 
(iNOS) and cytochromes of the 1 subfamily (CYP1A1).11 Another 
study shows that Cr(VI) causes alterations in DNA modification and 
microRNAs.12 Moreover, LUSC patients show lower Ti expression 
but higher miR- 24- 3p and miR- 28- 5p.13 Some other studies have 
found the association between the high lung cancer incidence and 
the contamination of metal elements in Xuanwei area.10,14 A recent 
study shows that the mean levels of heavy metals especially in the 
magnetic fractions within the road dust are rather higher than their 
background values.15
Thus, we suggested that the geological composition of the 
Xuanwei area may have special molecular mechanisms in the de-
velopment of lung cancer in these area . Furthermore, we would 
analyse the protein profiling changes of the lung cancer tissues 
form the patients of Xuanwei area, providing more insights to 
the large excess incidence of lung cancer in this area and find-
ing specific bio- molecular mechanisms involving the regional lung 
cancer.
2  | MATERIAL S AND METHODS
2.1 | Ethical statement
The experimental protocols were approved by the Ethics Committee 
of The Third Affiliated Hospital of Kunming Medical University and 
followed the guidelines of the 1975 Declaration of Helsinki. All pa-
tients in this study provided written informed consent.
2.2 | Specimen collection
Total 20 lung cancer tissues and 20 adjacent normal lung tissues were 
collected from The Third Affiliated Hospital of Kunming Medical 
University. All subjects were born and lived in Xuanwei area for more 
than 3 generations and with local bituminous coal contact history over 
10 years. The pathologic diagnosis was performed by a pathologist for 
all subjects of lung carcinoma. All the patients had not received any 
anti- tumour treatment before specimen collection. The clinic patho-
logical manifestations were acquired from the medical records of the 
patients. All the collected specimens were stored at −80°C until use.
2.3 | Cell culture
All of the lung cancer cell lines, including A549 and NCI- H1299, were 
purchased from Shanghai Cellular Research Institute and maintained 
in RPMI- 1640 medium (ScienCell) supplemented with 10% foetal 
bovine serum, 100 U/mL penicillin and 100 μg/mL streptomycin in a 
humidified incubator at 37°C with 5% CO2.
2.4 | Western blotting
The cells were treated under the indicated conditions and then ef-
ficient lysed with RIPA buffer at pH 8.0 (150 mM NaCl, 50 mM Tris, 
1% Triton X- 100, 0.5% sodium deoxycholate, 0.1% SDS). All the sam-
ples were quantified using PierceTM bicinchoninic acid (BCA) assay 
(Thermo Fisher Scientific Inc.) to ensure equal loading of proteins. 
The cellular protein samples were separated by SDS- PAGE and then 
transferred to a polyvinylidene difluoride membrane (Millipore). After 
blocked by 5% BSA, the membrane was probed with the primary an-
tibody and then incubated with HRP- conjugated secondary antibody 
in TBST. The primary antibodies include anti- TXN2 (1:1000 dilution, 
Abcam, ab185544) and anti- HP (1:1000 dilution, Abcam, ab256454).
2.5 | Quantitative RT- PCR
RNA extraction with a kit (Qiagen) and the PCR was ana-
lysed using an ABI 7300 Real- Time PCR System (Applied 
Biosystems) with the DreamTaq Green PCR Master Mix (2×). 
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The sequences of the primer pairs used for qRT- PCR were from 
previous report and presented as follows: HP HP- Forward 
primer: 5′- ATGACCTCCTTCACAAGCGC- 3′, HP- Reverse primer: 
5′- GAAGAGCCCTCAGGCTGGACT- 3′; TXN2- Forward: 5′- CTGGTG
GCCTGACTGTAACAC- 3′, TXN2- Reverse: 5′- TGACCACTCGGTCTT
GAAAGT- 3′; β- Actin- Forward: 5′- AGAGCTACGAGCTGCCTGAC- 3′, 
β- Actin- Reverse: 5′- AGCACTGTGTTGGCGTAC- 3′. Relative quanti-
tation of gene expression was assessed with analysing samples in 
triplicate and normalized by β- actin level.
2.6 | Cell viability assay
Cell viability was measured by a CCK- 8 kit (Beyotime) following the 
manufacturer's instruction.
2.7 | Iron quantification
Cells were seeded with 5 × 106 cells per plate and treated with eras-
tin or RSL3 for 24 hours. The iron assay kit (ab83366) was performed 
according to the manufacturers' protocols. The concentration of in-
tracellular ion was determined with a microplate reader at the ab-
sorption of 593 nm.
2.8 | Reactive oxygen species (ROS) assay
A superoxide indicator, dihydroethidium (DHE, Invitrogen), was 
added at the concentration of 5 μM into the medium and incubated 
with the cells for 1 hour at 37°C. Fluorescence was detected follow-
ing the kit instructions with the excitation at 485 nm and emission 
at 527 nm.
2.9 | Lipid peroxides measurement
To visualize the lipid ROS, cells of the designate treatments were 
stained with 2 μmol/L C11- BODIPY581/591 probe (Molecular 
Probes Inc.) in accordance with the manufacturer's instructions, 
30 minutes at 37°C in the dark; the cells were then stained with nu-
clear stain DAPI (G1012; Servicebio) for 10 minutes. Subsequently, 
cells were washed and ready for the analysis of Liperfluo with meas-
urement of the intensity of C11- BODIPY581/591 fluorescence.
2.10 | Malondialdehyde (MDA) assay
As a product of lipid peroxidation, MDA was measured based on 
the reaction between MDA and thiobarbituric acid using a commer-
cial kit (Beyotime Biotechnology).18 The activity of enzyme was re-
corded as U/mg protein. The mean values from assays were from 3 
independent experiments.
2.11 | Cell transfection
The siHP, siTXN2, siControl, the control pcDNA, pcDNA- TXN2 
and pcDNA- HP plasmids were synthesized by GenePharma 
Biotech and transfected into lung cancer cells with Lipofectamine 
2000 (Bioleaf Technology Co.) according to the manufacture's 
instruction.
2.12 | Animal experiments
All animal experiments strictly adhered to local regulations as well 
as LAWER (Laboratory Animal Welfare Ethics Review) guidelines 
(Andersen and Winter, 2017; Herrmann and Flecknell, 2018) and 
were approved by the local authorities before initiation. After 
48 hours of transfection to the A549 cell line with blank vector 
or combined siTXN2 and HP OE, the indicated tumour cells of 
1 × 106 in 100 μL of phosphate buffer saline (PBS) were planted 
into the back of BALB/c- nu mice. When the tumours reached 50 
mm3 at day 2, mice (n = 24) were allocated randomly into 3 groups 
and treated with PBS, erastin (30 mg/kg intraperitoneally, twice 
every other day) or RSL (10 mg/kg intraperitoneally, twice every 
other day). The tumour volume (tv) of experimental mice was 
observed 3 times every week. The tv was determined following 
equation: tv = ab2/2, in which a means the length of the tumour, 
and b means the width. The tumours were separated after mice 
were killed.
2.13 | High- performance liquid chromatography 
(HPLC) and mass spectrometry analysis
Each sample was prepared by subjecting to trypsin digestion and 
TMT labelling. After that, the resulted peptides were fractionated 
with a high- performance liquid chromatography (HPLC) system, and 
then, analysis of the peptides was performed with the Q ExactiveTM 
mass spectrometer (Thermo Finnigan).
HPLC consisted Easy nLC system with C18 column 
(10 cm × 75 μm i.d., 3 μm particle size) (Thermo Scientific); mobile 
phase A (0.1% formic acid in H2O) and mobile phase B (85% acetoni-
trile with 0.1% formic acid in H2O) consisted the binary solvent gra-
dient; and the elution procedure was performed as follows: initial 
A/B was 100:0 in volume, whereas B was linear from 0% to 35% at 
the first 50 minutes, and then reached to 100% at 55 minutes and 
held for another 5 minutes. The flow rate of mobile phase during 
gradient elution was 250 nL/min. Injection with an amount of 10 μL 
of samples and all samples was kept in an automatic injector at 4°C 
during the sequential analysis. Temperature of the column was kept 
at constant 25°C. Quality control samples were deployed in the 
sample queue to surveil the reliability of the raw data.
Mass spectrometry analyses were conducted with a Q- Exactive 
mass spectrometer with an orbitrap analyzer, using positive ESI. The 
ions with a range of 300 to 1800 m/z can be acquired. The duration 
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of dynamic exclusion was set 40.0 seconds. The resolution for the 
HCD spectra of MS/MS was set to 17 500 at m/z of 200. The nor-
malized collision energy was set at 30 eV, and the under- fill ratio at 
0.1%. Quality control samples were ran at an interval of 7 samples.
2.14 | Data processing
Mascot (version 2.5, Matrix Science) was used to analyse the MS/
MS spectra. Then, the data set was searched with the SWISS- PROT 
database. The TMT peptides were quantified by Scaffold version 
4.10.0 (Proteome Software, Inc.). Significant changes were defined 
as a threshold of ±1.2- fold change with P value < .05. Gene Ontology 
annotation, including biological processes, cellular components and 
molecular functions, was performed with BLAST2GO (version 2.7), 
and enrichment analysis of pathways for the differentially expressed 
proteins employed Kyoto Encyclopedia of Genes and Genomes 
(KEGG) automatic annotation server.
2.15 | Transmission electron microscopy (TEM)
The cells were washed with pre- cooled PBS (pH 7.4) and then post- 
fixed in 2.5% glutaraldehyde and 1% osmium tetroxide in phosphate- 
buffered solution. The samples were sequentially sliced and stained 
with 2% uranyl acetate (UA), dehydrated in ethanol with graded se-
ries and embedded in an epoxy resin. Finally, the sections (70- 90 nm) 
were stained with UA and lead citrate. Ultrastructural images were 
acquired with a TEM (Hitachi HT7700).
2.16 | Statistical analysis
Statistic Package for Social Science (SPSS) 20.0 statistical software 
was employed to perform data analysis. The differences were de-
noted with one- way ANOVA and considered as significant at P < .05.
3  | RESULTS
3.1 | Identification of differentially expressed gene 
in lung cancer
The scheme of the proteomic analysis is presented in Figure 1A. A 
total of 11 134 peptides in the clinic tissue samples were detected, 
which covers 3473 proteins; of these, 422 differentially expressed 
proteins (fold- change >1.2 or <0.83 in comparison with the para- 
carcinoma tissues, P < .05) were found in the analysis with quan-
titative information and were included in the next bioinformatics 
analysis. A volcano chart was drawn according to 2 factors, the fold- 
change and the p value obtained by t test, to show the significant dif-
ference in data between the two groups of samples (Figure 1B). We 
used the hierarchical cluster to compare the differentially expressed 
proteins of the representative cases, showing with the heat map 
(Figure 1C). The chart indicated that the threshold of fold- change 
set in the current study can effectively separate the cancer and the 
para- carcinoma groups, and the data of each case from the 2 groups 
were reproducible. According to the description about in GO terms 
and several recently published studies, various proteins, including 
TXN2, HP, PCNA, MYH7, POLG, TMEM62, TMEM16F, TMEM131L, 
SLC34A2, SLC35A3, SLC9A3R2, SLC44A2, HSPH1, HSPA5, LPCAT1, 
PPP1R14A and PPP2R5C, were screened out (Figure 1D) and subse-
quently subjected to qPCR validation (Figure 1E).
3.2 | OncoPPi network and critical pathway hubs
The 422 proteins (162 up- regulated and 260 down- regulated ver-
sus para- carcinoma tissues) were annotated according to their 
biological process, cellular component and molecular function by 
BLAST2TO (Figure 2A). Biological processes analysis showed that 
these proteins were mainly involved in single- organism process, 
localization, cellular component organization or biogenesis, biologi-
cal regulation and multicellular organismal process. Cellular com-
ponent analysis showed that most of the differential proteins were 
located in the extracellular region, membrane- enclosed lumen and 
organelle. Molecular function analysis revealed that a large propor-
tion of these proteins played a role in molecular function regulator, 
structural molecule activity, protein binding, transporter activity and 
molecular transducer activity. Pathway annotation by KEGG analy-
sis demonstrated that these differential proteins are mainly involved 
in ECM- receptor interaction, focal adhesion, small cell lung cancer, 
PI3K/AKT pathway and amoebiasis (Figure 2B). The above pathways 
might be involved in the lung cancer in this area.
TXN2 and HP were relatively in the centre of the PPI network 
of all differentially expressed gene (DEGs), implying some important 
roles that they might play in the progression of NSCLC (red arrow, 
Figure 2C). Other various ferroptosis- related proteins that were 
indicated with blue arrows (Figure 2C) were scattered on the net-
work, further suggesting that ferroptosis probably involved in the 
progression of NSCLC. In addition, we picked out TXN2 and HP to 
analyse more potential association with other possible molecules in 
ferroptosis (Figure 2D,E), and we noticed GPX4 (blue arrow), which 
is a documented key negative regulator of ferroptosis, and apolipo-
protein E (APOE) (blue arrow), a well- known lipid peroxidation inhib-
itor, are closely implicated. In addition, we noticed that there are few 
studies about these two proteins TXN2 and HP in ferroptosis. Based 
on these findings, we decided to pay more attention on these two 
molecules in the following research.
3.3 | Altered expression of Txn2 and HP in lung 
cancer was associated with ferroptosis
We validated the changes of TXN2 and HP in proteomics using 
several lung cancer cell lines and clinic samples (Figure 3A,B). We 
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observed that TXN2 was significantly decreased but HP increased 
in the cells treated with the ferroptosis inducers erastin, RSL or 
sorafenib at both mRNA and protein levels (Figure 3C,D), which in-
dicated that the trend in proteomic analysis was reversed by the in-
ducer. We hypothesized - that regulating the levels of TXN2 and HP 
in lung cancer cells would influence the cell proneness to ferroptosis.
3.4 | Survival analysis of TXN2
Using the online tool DriverDBv3 (http://drive rdb.tms.cmu.edu.tw/), 
whose data source is TCGA, TXN2 expression was found enhanced 
in LUSC (lung squamous cell carcinoma) but not in LUAD (lung ad-
enocarcinoma), compared to lung normal tissue (Figure 4A,B). To 
further explore the possible role of TXN2 in tumour progression of 
NSCLC, TXN2 expression in NSCLC from GEO public repository was 
analysed with GENT2 (http://gent2.appex.kr/gent2/). As a result, 
we found higher TXN2 levels at later clinical stages, though it was 
lower in at some stages (Figure 4C). If overexpressed TXN2 plays a 
role in progression of NSCLC, the patients with different TXN2 level 
may have different survival results. According to the survival analy-
sis results from Kaplan- Meier plotter (http://kmplot.com/analy sis/), 
the overall survival (OS) signature (high risk vs. low risk) of TXN2 
(Affymetrix ID: 209078_s_at) presents high- TXN2- expression pa-
tients’ overall survival time is shorter than that of low- expression 
NSCLC patients (hazard ratio [HR] 1.19; P = .0076), especially for 
LUAD (HR = 1.76, P = 2.7e- 6) (Figure 4D,E). In one of the above 
data sets (GSE31210, analysed with PrognoScan, http://dna00.bio.
kyute ch.ac.jp/Progn oScan/ index.html), apart from the OS result in 
Figure 4F (PROBE ID: 209077_at) which was consistent with that in 
Figure 4D, high- TXN2- expression patients also exhibited lower RFS 
(relapse free survival) in Figure 4G (PROBE ID: 209077_at). But for 
F I G U R E  1   The proteomic analysis for the clinic carcinoma and para- carcinoma tissues of the patients diagnosed as lung cancer in 
Xuanwei. A, The scheme of the proteomic analysis in this study. B, The volcano plot showed the differentially expressed genes in the clinic 
samples. C, Hierarchical clustering of the differentially expressed genes. For hierarchical clustering, blue and red indicate decreased and 
increased expression, respectively. The proteins were clustered by hierarchical clustering using the complete linkage algorithm and Pearson 
correlation metric in R. D, Heatmap of the proteins potentially related to ferroptosis. E, Relative protein level of the molecules potentially 
related to ferroptosis; data were collected from the proteomic analysis results
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LUSC, no significantly differences were found between low- TXN2 
and high- TXN2 groups (data not shown).
3.5 | Survival analysis of HP
HP expression data in LUAD and LUSC from TCGA were analysed with 
online tool DriverDBv3 (http://drive rdb.tms.cmu.edu.tw/), and it was 
found that HP was notably downregulated in both LUAD and LUSC 
tissues, compared to lung normal tissue (Figure 5A,B). The possible role 
of HP in tumour progression of NSCLC was revealed through analy-
sis of its expression in NSCLC using GENT2 (http://gent2.appex.kr/
gent2/) based on GEO public repository. However, lower HP at later 
clinical stages was not frequently observed (Figure 5C). According to 
the survival analysis results from The Human Protein Atlas (https://
www.prote inatl as.org/), low- HP- expression patients have a poorer 
overall survival in LUAD (Figure 5D) (cut- off = 0.81, P = .014), but quite 
in reverse, low- HP- expression patients have a better prognosis for 
F I G U R E  2   Bioinformatic analysis for the proteomic data and protein- protein interaction (PPI) networks. A, GO classification of the 
differential proteins by biological process, cellular component and molecular function. B, KEGG analysis of the differential proteins. To the 
left of each plot: KEGG terms. Under each plot: the percentage of the sequence. C, PPI network of all DEPs with a log2 (fold change) >1.2 or 
<0.83. The data were uploaded to the STRING 11.0 software to analyse the interactions among all DEPs. D, PPI network of TXN2- related 
proteins, including NDEPs and DEPs. E, PPI network of TXN2- related proteins, including NDEPs and DEPs. Coloured ball: the changed 
protein; yellow line: text mining; purple line: experiments; blue line: databases; light blue: homology; black line: co- expression; green 
line: neighbourhood; red line, gene fusion; deep blue: co- occurrence. DEPs: differentially expressed proteins; NDEPs: non- differentially 
expressed proteins
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LUSC (Figure 5E) (cut- off = 0.36, P = .002). To further validate the role 
of HP in prognosis of NSCLC, we analysed the survival of patients with 
low or high HP expression using Kaplan- Meier plotter (http://kmplot.
com/analy sis/) that mainly contains GEO (gene expression omnibus) 
data sets. Against our prediction and the aforesaid result from TCGA, 
the low- HP- expression (Affymetrix ID: 206697_s_at) patients’ over-
all survival was better, consistent with which, these patients showed 
longer time till first progression (Figure 5F,G). In addition, according 
the survival analysis results from GEO data sets, HP expression level 
showed no effect on LUSC patients’ survival (data not shown).
3.6 | Altered TXN2 and HP linked to ferroptosis in 
lung cancer cell lines in vitro
We overexpressed TXN2 or interfered with HP in lung cancer 
cell lines (A549 and NCI- H11299). The efficiency of TXN2 over-
expression and HP depletion was confirmed by Western blotting 
(Figure 6A); the mRNA level of TXN2 overexpression and HP de-
pletion induced by erastin or RSL was also detected, as shown 
in Figure 6B; and erastin or RSL were unable to eliminate TXN2 
expression with TXN2 overexpression, whereas erastin or RSL 
F I G U R E  3   Validation of proteomics results. A, Two differentially expressed proteins TXN2 and HP in lung cell lines were detected by 
Western blotting. *, P < .05. B, The proteomics results of TXN2 and HP were validated in the clinic samples. TP, tumour peripheral tissue; 
TT, tumour tissue. *, P < .05. C, The expression of TXN2 and HP at mRNA level under the treatment of ferroptosis inducer, erastin (10 µM), 
RSL (1 µM) or sorafenib (5 μM). *, P < .05; **, P < .01. D, The expression of TXN2 and HP at protein level under the treatment of ferroptosis 
inducer, erastin (10 µM), RSL (1 µM) or sorafenib (5 μM)
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were unable to induce HP expression with HP depletion. Cell vi-
ability results revealed that the transfected cells became more 
resistance to increasing dose of erastin or RSL- induced cell death 
compared to non- transfected cells by showing higher rates of sur-
vival (Figure 6C). The levels of Fe2+ were remarkably decreased 
(Figure 6D). MDA assays indicated the lower oxidative metabolism 
of lipids in the blank lung cancer cells under the erastin or RSL treat-
ment, whereas the transfected cells had a lower level of membrane 
lipid oxidation (Figure 6E). Similarly, changes in ROS also indicated 
a significant decrease in oxidation levels of the transfected cells 
under erastin or RSL treatment (Figure 6F). The GSH assays showed 
that the GSH in the transfected cells was higher (Figure 6G). TXN2 
overexpression or HP depletion decreased erastin and RSL- induced 
lipid oxidation in lung cancer cell lines, which were shown by the 
green fluorescence intensity (levels of oxidized C11 BODIPY 
581/591) (Figure 6H). We found in (Figure S1); however, cell deaths 
and MDA levels induced by ferroptosis inducers would not be re-
versed by caspase pharmacological inhibitor ZV AD- FMK and the 
necroptosis inhibitor, Necrosulfonamide, in A549 and NCI- H1299 
cell lines, which could be inhibited by specific ferroptosis inhibitor 
ferrostatin. This verified the effects of ferroptosis on lung cancer 
cells and excluded other regulated cell death forms, like apoptosis 
and necroptosis. All these results suggested that TXN2 overex-
pression and HP depletion promoted lung cancer resistance were 
through attenuating ferroptosis.
Then, we overexpressed HP or interfered with TXN2 in lung 
cancer cell lines; the protein level of HP and TXN2 was detected 
(Figure 7A); the mRNA level of HP overexpression and TXN2 deple-
tion induced by erastin or RSL was also detected (Figure 7B); and 
results showed that erastin or RSL further eliminated TXN2 expres-
sion with TXN2 knockdown, whereas erastin or RSL further induced 
HP expression with HP overexpression. We observed that the trans-
fected cells became more prone to erastin or RSL- induced ferro-
ptosis compared to non- transfected cells by showing lower rates of 
survival (Figure 7C). Moreover, we also found that the levels of Fe2+ 
(Figure 7D), MDA (Figure 7E), intracellular lipid ROS (Figure 7F) and 
lipid peroxidation (Figure 7H) in A549 and NCI- H11299 were remark-
ably increased and GSH was decreased (Figure 7G). Nonetheless, 
the effect of both erastin and RSL along with HP overexpression or 
TXN2 depletion on cell survival levels of Fe2+, MDA, intracellular lipid 
ROS, lipid peroxidation and GSH could be reversed by ferrostatin 
(Figure 7C- G).Observation by TEM revealed that the lung cancer cells 
with interference of TXN2 or overexpression of HP had smaller mito-
chondria and a decreased number of mitochondrial cristae under the 
treatment of erastin or RSL, and the proportion of mitochondria with 
ruptured outer membrane increased in these cells (Figure 7I). These 
results suggested that upregulating of HP but downregulating TXN2 
can increase the ferroptosis rate of lung cancer cells.
3.7 | TXN2 and HP were associated with lung 
cancer development in vivo
In vitro, both knocking down of TXN2 and overexpression of HP 
were observed to modulate sensitivity of lung cancer cell lines to 
erastin and RSL. Afterwards, we constructed the siTXN2 but HP- 
overexpressing A549 cells and performed the tumorigenicity tests 
using the wild- type A549 and the co- transfected A549 cells on nude 
F I G U R E  4   TXN2 expression profile in NSCLC and its role in prognosis. A- B, TXN2 expression in LUAD (lung adenocarcinoma), LUSC (lung 
squamous cell carcinoma) and lung normal tissues. C, TXN2 expression in NSCLC, including LUAD, LUSC and LCLC (large cell lung cancer), 
from GEO public repository showed higher levels in at later clinical stages. D- E, Overall survival analysis of low- TXN2 and high- TXN2 NSCLC 
(LUAD and LUSC); D) patients or LUAD patients (E); patients split by median; probe: 209078_s_at. (F- G) Overall survival and RFS (relapse 
free survival) analyses of low- TXN2 and high- TXN2 LUAD patients; probe: 209077_at
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mice. The efficiency of transfected cells is shown in Figure 8A. When 
the tumours reached 50 mm3 at day 2, mice were treated with eras-
tin for 26 days (Figure 8B). We also found that the co- transfected 
cells were more sensitive to erastin or RSL treatment in vivo, which 
showed that the tumour volume was much smaller than the group 
of wild- type A549 at 28 days after implantation (Figure 8C,D). 
Therefore, promoting the development of lung cancer by inhibiting 
ferroptosis may be a potential and special mechanism for the high 
incidence of lung cancer in Xuanwei.
4  | DISCUSSION
The Xuanwei area in Yunnan Province is a high- risk area for lung 
cancer. As it is the main coal mining area in south- western China, 
several geochemical studies have shown that mineral elements are 
associated with a high incidence of lung cancer in this area.10,16 To 
date, the cause of high occurrence of lung cancer in Xuanwei area 
remains far from clear.
To identify the vital candidates for lung cancer pathogenesis of 
patients from Xuanwei, bioinformatic methods were applied firstly. 
Microarray study was used to analyse the altered protein profil-
ing between carcinoma and para- carcinoma tissues from Xuanwei 
area, and then, pathway enrichment was used to explore the inter-
actions of these differential proteins and the present study showed 
pathways enriched in 5 processes including small cell lung cancer, 
ECM- receptor interaction, focal adhesion, PI3K/AKT and amoebia-
sis. Apart from amoebiasis, the above pathways like ECM- receptor 
interaction and adhesive attraction17 and PI3K/AKT18 are greatly 
noted in lung cancer previously, which may be responsible for lung 
cancer cell invasion and metastasis. In addition, centrally involved 
TXN2 and HP as two key factors of the PPI network were identified. 
Also, our network analysis implicated that TXN2 associated with 
the established negative ferroptosis regulator GPX4 and HP inter-
connected with the lipid peroxidation inhibitor APOE; moreover, 
both TXN2 and HP are ferroptosis- related molecules. Ferroptosis is 
a recently identified form of cell death, which differs from apopto-
sis, cell necrosis and autophagy. It is caused by the accumulation of 
the products of iron- dependent lipid peroxidation.19,20 Considering 
the growth of cancer cell is iron dependency, which means can-
cer cell including lung cancer can evade apoptosis but to be more 
susceptible to an iron- induced ferroptosis. Morphologically, the 
cells showed a decrease in volume, an increase in mitochondrial 
membrane density and disappearance of mitochondrial cristae 
during ferroptosis.21 At the molecular level, phospholipid- bound 
polyunsaturated fatty acids (PL- PUFAs) are peroxidized during 
ferroptosis to generation ROS and achieve cell kill, which can be 
eliminated by 3 parallel pathways: GPX4- glutathione, fibroblast- 
specific protein 1 (FSP1)- CoQ10 and guanosine triphosphate cy-
clohydrolase 1 (GCH)1- BH4.22 Several other molecules have been 
found to regulate ferroptosis in lung cancer, such as the erythroid 
2- related factor 2 (Nrf2)23 and serine threonine tyrosine kinase 1 
(STYK1).24 Besides, growing evidences suggest an important lethal 
role for iron and ferroptosis in lung cancer.25 Given that the main 
emitted chemical particle from coal combustion is iron in Xuanwei, 
which is reducible and could generate ROS, a study focused on the 
valence state of iron in size- resolved particle found that oxidizable 
iron accounts for a large proportion of raw coal samples, whereas a 
large percentage of redox- active fractions of iron (46%- 78%) in fly 
ash particles after coal combustion. In addition, the concentration 
F I G U R E  5   HP expression profile in NSCLC and its role in prognosis. A- B, HP expression in LUAD, LUSC and lung normal tissues. C, HP 
expression in NSCLC, including LUAD, LUSC and LCLC, from GEO public repository showed higher levels in at later clinical stages. D- E, 
Overall survival analysis of low- HP and high- HP LUAD (D) or LUSC (E) patients. F- G, Overall survival and FP (first progression) analyses of 
low- HP and high- HP LUAD patients; probe: 206697_s_at
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of ·OH was higher in fine particles than coarse particles.26 Thus, we 
guess ion may link to lung cancer, and ferroptosis may be responsi-
ble for Xuanwei lung cancer.
As an important antioxidant defence mechanism, TXN system 
has attracted researchers' attention to its role in ferroptosis.27 The 
persistent activation of antioxidant systems and overexpression of 
thioredoxin via genetic alterations in Nrf2 and Keap1 also contrib-
utes to carcinogenesis.28 Moreover, a recent study reported genetic 
knockdown of TXN leads to accumulation of lipid ROS levels and 
induces an antioxidant response to cause ferroptosis, a potential 
pro- ferroptotic agent due to its inhibition of TXN would be an anti- 
cancer therapeutic strategy.29 HP is a plasma protein that has the 
ability to combine with free haemoglobin, which allows hepatic re-
cycling of heme iron to function in preventing kidney from damage. 
HP also has antibacterial activity and plays an essential role in reg-
ulating responses under the acute phase.30 The expression of HP 
was found increased after intracerebral haemorrhage in vivo, which 
could prevent haemoglobin- induced neuronal ferroptosis is as an 
antioxidant.31 HP polymorphism causes change in haemoglobin- bind 
capacity, antioxidant and iron- recycling activities, which may be im-
portant for effective oxidative stress response in lung cancer patho-
genic process.32 Specifically, in the present study, we supposed that 
HP and TXN2 may be involved in ferroptosis and contribute to lung 
cancer in Xuanwei area.
It was revealed that TXN2 up- regulated and HP downregulated 
in lung cancer cell tissues of Xuanwei patients and 3 lung cancer 
cell lines. Public data also supported that TXN2 enhanced in LUSC 
but not in LUAD, HP downregulated in both LUAD and LUSC. 
Online data showed higher TXN2 levels at later clinical stages, 
whereas lower HP at later clinical stages was not frequently ob-
served. Kaplan- Meier survival analysis suggested that higher 
TXN2 levels and lower HP levels might be unfavourable factors of 
in LUAD prognosis.
In addition, the results also indicated that ferroptosis inducer 
erastin or RSL downregulated TXN2 and up- regulated HP. Further 
experiments with overexpressed TXN2 or interfered with HP in 
F I G U R E  6   TXN2 overexpression and HP depletion promoted resistance of lung cancer cell lines through attenuating ferroptosis. A, The 
efficiency of transfected cells was analysed via Western blot assays. B, qPCR showed TXN2 and HP expression with erastin (10 µM) or RSL 
(1 µM) treatment for 24 h. C, Cell viability assays for the cells with the increasing erastin or RSL treatments for 72 h. The iron concentrations 
(D), MDA concentrations (E), the relative ROS levels (F) and the GSH concentrations (G) of the cells under the treatment of erastin (10 µM) or 
RSL (1 µM) for 24 h. H, Analysis of C11- BODIPY581/591 fluorescence (scale bar = 10 μm). *P < .05; **, P < .01
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F I G U R E  7   TXN2 depletion and HP overexpression enhanced ferroptosis in lung cancer cell lines A549 and NCI- H1299. A, The efficiency 
of transfected cells was analysed via Western blot assays. B, qPCR showed TXN2 and HP expression with erastin (10 µM) or RSL (1 µM) 
treatment for 24 h. C, Cell viability assays for the cells with erastin (10 µM) or RSL (1 µM) treatment for 24 h. The iron concentrations (D), 
MDA concentrations (E), the relative ROS levels (F), the GSH concentrations (G) of the cells under the treatment of erastin (10 µM) or RSL 
(1 µM) for 24 h. H, Analysis of C11- BODIPY581/591 fluorescence (scale bar = 10 μm). I, The alterations of mitochondrial ultrastructure of the 
indicated cells and white arrows indicated mitochondria (scale bar = 500 nm). NC, negative control; EV, empty vector; OE, overexpressing; *, 
P < .05, **, P < .01
F I G U R E  8   The expressions of TXN2 
and HP affected ferroptosis in nude mice. 
A, The efficiency of TXN2 and HP. B, The 
tumour volume was monitored weekly. 
*, P < .05. C- D, The tumour sizes at 
28 days after implantation
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lung cancer cell lines demonstrated that TXN2 overexpression and 
HP depletion promoted lung cancer resistance to erastin or RSL- 
induced cell death were through attenuating ferroptosis, whereas 
upregulating of HP but downregulating TXN2 increased the fer-
roptosis rate of lung cancer cells. The increase of cell death and 
MDA by erastin and RSL could not be affected with inhibitors of 
these two pathways in our study, which distinguished ferroptosis 
from apoptosis and necroptosis. That ferrostatin inhibited the in-
hibitory effects of altered TXN2 and HP may validate functions 
of TXN2 and HP during ferroptosis. Besides, co- transfected with 
siTXN2 and HP overexpression vector significantly increased the 
size, volume of the tumour in vivo. Together, our results demon-
strate that down- regulated TXN2 and up- regulated HP made the 
cancer cells more resistant, which could be a specific mechanism 
for the lung cancer in Xuanwei area. Further studies are needed to 
verify the changes in a larger cohort and to establish the associa-
tion between the molecules and the high incidence of lung cancer 
in Xuanwei area.
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